| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.07 |